QCM
BSX icon

QRG Capital Management’s Boston Scientific BSX Stock Holding History

QRG Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
362,716
+198,951
+121% +$10.8M 0.13% 148
2026
Q1 		$10.3M Buy
163,765
+1,372
+0.8% +$110K 0.11% 177
2025
Q4 		$15.5M Sell
162,393
-1,580
-1% -$155K 0.17% 119
2025
Q3 		$16M Sell
163,973
-18,627
-10% -$1.93M 0.19% 103
2025
Q2 		$19.6M Buy
182,600
+18,238
+11% +$1.85M 0.17% 131
2025
Q1 		$16.6M Buy
164,362
+52,641
+47% +$5.3M 0.17% 131
2024
Q4 		$9.98M Buy
111,721
+7,259
+7% +$639K 0.1% 187
2024
Q3 		$8.75M Buy
104,462
+18,573
+22% +$1.46M 0.09% 192
2024
Q2 		$6.61M Sell
85,889
-7,309
-8% -$535K 0.08% 220
2024
Q1 		$6.38M Buy
93,198
+7,065
+8% +$454K 0.08% 224
2023
Q4 		$4.98M Buy
86,133
+9,453
+12% +$505K 0.07% 259
2023
Q3 		$4.05M Buy
+76,680
New +$4.02M 0.07% 262

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

QRG Capital Management's BSX Position: Q2 2026 in Review

QRG Capital Management increased its Boston Scientific (BSX) stake by 121% in Q2 2026, buying an estimated $10.8M and bringing the position to 362,716 shares worth $15.5M. The position accounts for 0.13% of the portfolio, ranked #148.

QRG Capital Management first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $19.6M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • QRG Capital Management held 362,716 shares of Boston Scientific worth $15.5M as of Q2 2026.
  • QRG Capital Management bought 198,951 Boston Scientific shares in Q2 2026, an estimated $10.8M.
  • Boston Scientific made up 0.13% of QRG Capital Management's portfolio in Q2 2026, its #148 holding.
  • QRG Capital Management first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Boston Scientific position peaked at $19.6M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.